The effect of platelet-rich plasma and bone marrow on murine posterolateral lumbar spine arthrodesis with bone morphogenetic protein

Journal of Bone and Joint Surgery

Volumn 91, Issue 5, 2009, Pages 1199-1206

  Rao, Raj D ^a   Gourab, Krishnaj ^a   Bagaria, Vaibhav B ^a   Shidham, Vinod B ^a   Metkar, Umesh ^a   Cooley, Brian C ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN SPONGE; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTHRODESIS; ARTICLE; BONE MARROW; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; HISTOLOGY; LUMBAR SPINE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPINE FUSION; SPINE RADIOGRAPHY; SPINE SURGERY; SURGICAL TECHNIQUE; THROMBOCYTE RICH PLASMA; TREATMENT OUTCOME;

ANIMALS; BLOOD PLATELETS; BONE MARROW TRANSPLANTATION; BONE MORPHOGENETIC PROTEINS; LUMBAR VERTEBRAE; MALE; MICE; PLASMA; RECOMBINANT PROTEINS; SPINAL FUSION; TRANSFORMING GROWTH FACTOR BETA;

EID: 70350066322     PISSN: 00219355     EISSN: None     Source Type: Journal    
DOI: 10.2106/JBJS.G.01375     Document Type: Article

References (47)

1. Vaccaro AR, Anderson DG, Patel T, Fischgrund J, Truumees E, Herkowitz HN, Phillips F, Hilibrand A, Albert TJ, Wetzel T, McCulloch JA. Comparison of OP-1 Putty (rhBMP-7) to iliac crest autograft for posterolateral lumbar arthrodesis: a minimum 2-year follow-up pilot study. Spine. 2005;30:2709-2716 (Pubitemid 43011029)
2. Boden SD, Kang J, Sandhu H, Heller JG. Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial. Spine. 2002;27:2662-2673 (Pubitemid 35425320)
3. Vaccaro AR, Patel T, Fischgrund J, Anderson DG, Truumees E, Herkowitz HN, Phillips F, Hilibrand A, Albert TJ, Wetzel T, McCulloch JA. A pilot study evaluating the safety and efficacy of OP-1 Putty (rhBMP-7) as a replacement for iliac crest autograft in posterolateral lumbar arthrodesis for degenerative spondylolisthesis. Spine. 2004;29:1885-1892 (Pubitemid 39181046)
4. Younger EM, Chapman MW. Morbidity at bone graft donor sites. J Orthop Trauma. 1989;3:192-195
5. Arrington ED, Smith WJ, Chambers HG, Bucknell AL, Davino NA. Complications of iliac crest bone graft harvesting. Clin Orthop Relat Res. 1996;329:300-309 (Pubitemid 26274684)
6. Goulet JA, Senunas LE, DeSilva GL, Greenfield ML. Autogenous iliac crest bone graft. Complications and functional assessment. Clin Orthop Relat Res. 1997;339:76-81.
7. Dimar JR, Glassman SD, Burkus KJ, Carreon LY. Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2/compression resistant matrix versus iliac crest bone graft. Spine. 2006;31:2534-2540
8. Glassman SD, Dimar JR, Carreon LY, Campbell MJ, Puno RM, Johnson JR. Initial fusion rates with recombinant human bone morphogenetic protein-2/compression resistant matrix and a hydroxyapatite and tricalcium phosphate/collagen carrier in posterolateral spinal fusion. Spine. 2005;30:1694-1698
9. Martin GJ Jr, Boden SD, Marone MA, Marone MA, Moskovitz PA. Posterolateral intertransverse process spinal arthrodesis with rhBMP-2 in a nonhuman primate: important lessons learned regarding dose, carrier, and safety. J Spinal Disord. 1999;12:179-186
10. Johnsson R, Strömqvist B, Aspenberg P. Randomized radiostereometric study comparing osteogenic protein-1 (BMP-7) and autograft bone in human non-instrumented posterolateral lumbar fusion: 2002 Volvo Award in clinical studies. Spine. 2002;27:2654-2661 (Pubitemid 35425319)
11. Roostaeian J, Carlsen B, Simhaee D, Jarrahy R, Huang W, Ishida K, Rudkin GH, Yamaguchi DT, Miller TA. Characterization of growth and osteogenic differentiation of rabbit bone marrow stromal cells. J Surg Res. 2006;133:76-83.
12. Sciadini MF, Johnson KD. Evaluation of recombinant human bone morphogenetic protein-2 as a bone-graft substitute in a canine segmental defect model. J Orthop Res. 2000;18:289-302.
13. Rao RD, Bagaria VB, Cooley BC. Posterolateral intertransverse lumbar fusion in a mouse model: surgical anatomy and operative technique. Spine J. 2007;7:61-67
14. Connolly JF. Injectable bone marrow preparations to stimulate osteogenic repair. Clin Orthop Relat Res. 1995;313:8-18.
15. Romih M, Delécrin J, Heymann D, Passuti N. The vertebral interbody grafting site's low concentration in osteogenic progenitors can greatly benefit from addition of iliac crest bone marrow. Eur Spine J. 2005;14:645-648 (Pubitemid 41414081)
16. Muschler GF, Boehm C, Easley K. Aspiration to obtain osteoblast progenitor cells from human bone marrow: the influence of aspiration volume. J Bone Joint Surg Am. 1997;79:1699-709. Erratum in: J Bone Joint Surg Am. 1998;80:302. (Pubitemid 27508530)
17. Assoian RK, Komoriya A, Meyers CA, Miller DM, Sporn MB. Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization. J Biol Chem. 1983;258:7155-7160
18. Slater M, Patava J, Kingham K, Mason RS. Involvement of platelets in stimulating osteogenic activity. J Orthop Res. 1995;13:655-663
19. Piché JE, Graves DT. Study of the growth factor requirements of human bone-derived cells: a comparison with human fibroblasts. Bone. 1989;10:131-138 (Pubitemid 19213555)
20. Thor A. Reconstruction of the anterior maxilla with platelet gel, autogenous bone, and titanium mesh: a case report. Clin Implant Dent Relat Res. 2002;4:150-155
21. Catalfamo JL, Dodds WJ. Isolation of platelets from laboratory animals. Methods Enzymol. 1989;169:27-34.
22. Weibrich G, Hansen T, Kleis W, Buch R, Hitzler WE. Effect of platelet concentration in platelet-rich plasma on peri-implant bone regeneration. Bone. 2004;34:665-671 (Pubitemid 38393802)
23. Office of Laboratory Animal Welfare. Institute of Laboratory Animal Research. http://grants1.nih.gov/grants/olaw/. Accessed 2008 Nov 10.
24. Salamon ML, Althausen PL, Gupta MC, Laubach J. The effects of BMP-7 in a rat posterolateral intertransverse process fusion model. J Spinal Disord Tech. 2003;16:90-95 (Pubitemid 36184260)
25. Boden SD, Martin GJ Jr, Morone MA, Ugbo JL, Moskovitz PA. Posterolateral lumbar intertransverse process spine arthrodesis with recombinant human bone morphogenetic protein 2/Hydroxyapatite-tricalcium phosphate after laminectomy in the nonhuman primate. Spine. 1999;24:1179-1185 (Pubitemid 29279459)
26. Liao SS, Guan K, Cui FZ, Shi SS, Sun TS. Lumbar spinal fusion with a mineralized collagen matrix and rhBMP-2 in a rabbit model. Spine. 2003;28:1954-1960 (Pubitemid 37082660)
27. Schimandle JH, Boden SD, Hutton WC. Experimental spinal fusion with recombinant human bone morphogenetic protein-2. Spine. 1995;20:1326-1337
28. Boden SD, Zdeblick TA, Sandhu HS, Heim SE. The use of rhBMP-2 in interbody fusion cages. Definitive evidence of osteoinduction in humans: a preliminary report. Spine. 2000;25:376-381
29. Sandhu HS, Kanim LE, Kabo JM, Toth JM, Zeegen EN, Liu D, Delamarter RB, Dawson EG. Effective doses of recombinant human bone morphogenetic protein-2 in experimental spinal fusion. Spine. 1996;21:2115-2122 (Pubitemid 26330597)
30. ImageJ. http://rsb.info.nih.gov/ij/. Accessed 2008 Nov 10.
31. Burkus JK, Gornet MF, Dickman CA, Zdeblick TA. Anterior lumbar interbody fusion using rhBMP-2 with tapered interbody cages. J Spinal Disord Tech. 2002;15:337-349 (Pubitemid 35403089)
32. Hanada K, Dennis JE, Caplan AI. Stimulatory effects of basic fibroblast growth factor and bone morphogenetic protein-2 on osteogenic differentiation of rat bone marrow-derived mesenchymal stem cells. J Bone Miner Res. 1997;12:1606-1614 (Pubitemid 27422361)
33. Kai T, Shao-qing G, Geng-ting D. In vivo evaluation of bone marrow stromal-derived osteoblasts-porous calcium phosphate ceramic composites as bone graft substitute for lumbar intervertebral spinal fusion. Spine. 2003;28:1653-1658
34. Peng H, Wright V, Usas A, Gearhart B, Shen HC, Cummins J, Huard J. Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. J Clin Invest. 2002;110:751-759 (Pubitemid 35050952)
35. Wang JC, Kanim LE, Yoo S, Campbell PA, Berk AJ, Lieberman JR. Effect of regional gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats. J Bone Joint Surg Am. 2003;85:905-911 (Pubitemid 36548641)
36. Minamide A, Yoshida M, Kawakami M, Okada M, Enyo Y, Hashizume H, Boden SD. The effects of bone morphogenetic protein and basic fibroblast growth factor on cultured mesenchymal stem cells for spine fusion. Spine. 2007;32:1067-1071 (Pubitemid 46685982)
37. Finkemeier CG. Bone-grafting and bone-graft substitutes. J Bone Joint Surg Am. 2002;84:454-464
38. Cheng H, Jiang W, Phillips FM, Haydon RC, Peng Y, Zhou L, Luu HH, An N, Breyer B, Vanichakarn P, Szatkowski JP, Park JY, He TC. Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). J Bone Joint Surg Am. 2003;85:1544-1552
39. Canalis E, McCarthy TL, Centrella M. Effects of platelet-derived growth factor on bone formation in vitro. J Cell Physiol. 1989;140:530-537 (Pubitemid 19241771)
40. Miyazono K, Takaku F. Platelet-derived growth factors. Blood Rev. 1989;3:269-276
41. Sim R, Liang TS, Tay BK. Autologous marrow injection in the treatment of delayed and non-union in long bones. Singapore Med J. 1993;34:412-417
42. Goel A, Sangwan SS, Siwach RC, Ali AM. Percutaneous bone marrow grafting for the treatment of tibial non-union. Injury. 2005;36:203-206 (Pubitemid 39611330)
43. Korovessis P, Koureas G, Zacharatos S, Papazisis Z, Lambiris E. Correlative radiological, self-assessment and clinical analysis of evolution in instrumented dorsal and lateral fusion for degenerative lumbar spine disease. Autograft versus coralline hydroxyapatite. Eur Spine J. 2005;14:630-638
44. Lowery GL, Kulkarni S, Pennisi AE. Use of autologous growth factors in lumbar spinal fusion. Bone. 1999;25(2 Suppl):47S-50S. (Pubitemid 29333178)
45. Carreon LY, Glassman SD, Anekstein Y, Puno RM. Platelet gel (AGF) fails to increase fusion rates in instrumented posterolateral fusions. Spine. 2005;30:E243-7.
46. Weiner BK, Walker M. Efficacy of autologous growth factors in lumbar intertransverse fusions. Spine. 2003;28:1968-1971 (Pubitemid 37082662)
47. Bose B, Balzarini MA. Bone graft gel: autologous growth factors used with autograft bone for lumbar spine fusions. Adv Ther. 2002;19:170-175 (Pubitemid 35278523)